 |
ALX-0081 nanobody, directed towards the human A1 domain of von Willebrand factor |
|---|---|
| Trade Name | |
| Orphan Indication | Thrombotic thrombocytopenic purpura |
| USA Market Approval | USA |
| USA Designation Date | 2009-04-14 00:00:00 |
| Sponsor | Ablynx NV;Technologiepark 21, B-9052;Zwijnaarde |
